PF019 TIMP-1, Human, Recombinant, CHO Cells

PF019
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      PF019-3UG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 3 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewRecombinant, human TIMP-1 expressed in CHO cells. Migrates as a 28 kDa protein under reducing conditions on SDS-PAGE.
          Catalogue NumberPF019
          Brand Family Calbiochem®
          SynonymsTissue Inhibitor of Metalloproteinase-1
          References
          ReferencesFreudenstein, J. et al. 1990. Biochem. Biophys. Res. Comm. 171, 250.
          Liotta, L. A., and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol. 1, 99.
          Kodama, S. et al. 1987. Collagen Rel. Res. 7, 341.
          Docherty, A.J.P. et al. 1985. Nature 318, 66.
          Nagai, Y., et al. 1984. Jpn. J. Inflam. 4, 123.
          Product Information
          ATP CompetitiveN
          DeclarationManufactured by Daiichi Fine Chemical Co., Ltd. Not available for sale in Japan.
          FormLyophilized
          FormulationLyophilized from ammonium bicarbonate, sodium chloride, sodium phosphate buffer, 100 µg BSA, pH 7.3.
          PreservativeNone
          ReversibleN
          Applications
          Application ReferencesInhibition Studies Nagai, Y., et al. 1984. Jpn. J. Inflam. 4, 123.
          Application NotesImmunoblotting Standard (20 µl/lane)
          MMP Inhibition (assay dependent, see comments)
          Application CommentsTIMPs bind MMPs in a 1:1 stoichiometric ratio, but due to the variable concentration of MMPs in biological samples the optimal amount of TIMP-1 will be assay dependent and should be determined by titration. It is reported that TIMP-1 inhibits 6.7 nM MMP-1 with an IC50 of 1-5 nM (see application references).
          Biological Information
          Biological activityIC₅₀ against native human MMP-1 is ~1-5 nM.
          Primary TargetHuman MMP 1
          Primary Target IC<sub>50</sub>1-5 nM against human MMP 1
          Purity≥95% by SDS PAGE (prior to lyophilization)
          Physicochemical Information
          Cell permeableN
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          TIMP-1, Human, Recombinant, CHO Cells SDS

          Title

          Safety Data Sheet (SDS) 

          TIMP-1, Human, Recombinant, CHO Cells Certificates of Analysis

          TitleLot Number
          PF019

          References

          Reference overview
          Freudenstein, J. et al. 1990. Biochem. Biophys. Res. Comm. 171, 250.
          Liotta, L. A., and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol. 1, 99.
          Kodama, S. et al. 1987. Collagen Rel. Res. 7, 341.
          Docherty, A.J.P. et al. 1985. Nature 318, 66.
          Nagai, Y., et al. 1984. Jpn. J. Inflam. 4, 123.

          Citations

          Title
        • William J. Lane, et al. (2000) Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96, 4152-4159.
        • Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision06-September-2007 JSW
          SynonymsTissue Inhibitor of Metalloproteinase-1
          ApplicationImmunoblotting Standard (20 µl/lane)
          MMP Inhibition (assay dependent, see comments)
          DescriptionRecombinant, human TIMP-1 expressed in CHO cells. Migrates as a ~28 kDa protein by SDS-PAGE. The activation and activity of matrix metalloproteinases (MMPs) are regulated by a family of endogenous inhibitors, tissue inhibitors of metalloproteinase (TIMP). TIMP-1 is a ~28 kDa glycoprotein that is expressed by a variety of cell types. It forms a non-covalent, stoichiometric complex with both latent and active MMPs. TIMP-1 preferentially binds and inhibits MMP-9. TIMPs are capable of altering the metastatic potential of cancer cells and have been shown to inhibit invasion and metastasis in animal models.
          BackgroundThe activation and activity of matrix metalloproteinases (MMPs) are regulated by a family of endogenous inhibitors, tissue inhibitors of metalloproteinase (TIMP). TIMP-1 is a 28 kDa glycoprotein that is expressed by a variety of cell types. It forms a non-covalent, stoichiometric complex with both latent and active MMPs. TIMP-1 preferentially binds and inhibits MMP-9. TIMPs are capable of altering the metastatic potential of cancer cells and have been shown to inhibit invasion and metastasis in animal models.
          FormLyophilized
          FormulationLyophilized from ammonium bicarbonate, sodium chloride, sodium phosphate buffer, 100 µg BSA, pH 7.3.
          Recommended reaction conditions
          Immunoblotting Standard Useful as an immunoblotting standard; use at 20 µl/lane for most applications. MMP Inhibition Assays TIMPs bind MMPs in a 1:1 stoichiometric ratio, but due to the variable concentration of MMPs in biological samples the optimal amount of TIMP-1 will be assay dependent and should be determined by titration. It is reported that TIMP-1 inhibits 6.7 nM MMP-1 with an IC50 of 1-5 nM (see application references).
          Purity≥95% by SDS PAGE (prior to lyophilization)
          Biological activityIC₅₀ against native human MMP-1 is ~1-5 nM.
          SolubilityReconstitute with PBS to the desired concentration and mix gently until completely dissolved.
          PreservativeNone
          CommentsTIMPs bind MMPs in a 1:1 stoichiometric ratio, but due to the variable concentration of MMPs in biological samples the optimal amount of TIMP-1 will be assay dependent and should be determined by titration. It is reported that TIMP-1 inhibits 6.7 nM MMP-1 with an IC50 of 1-5 nM (see application references).
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Toxicity Standard Handling
          ReferencesFreudenstein, J. et al. 1990. Biochem. Biophys. Res. Comm. 171, 250.
          Liotta, L. A., and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol. 1, 99.
          Kodama, S. et al. 1987. Collagen Rel. Res. 7, 341.
          Docherty, A.J.P. et al. 1985. Nature 318, 66.
          Nagai, Y., et al. 1984. Jpn. J. Inflam. 4, 123.
          Citation
        • William J. Lane, et al. (2000) Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96, 4152-4159.
        • Application referencesInhibition Studies Nagai, Y., et al. 1984. Jpn. J. Inflam. 4, 123.